Marksans Pharma
BSE: 524404 | NSE: MARKSANS | ISIN: INE750C01026 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
20.12Net Income/employee - trailing 12 month
22,85,450.00Revenue/employee - most recent fiscal year
1,31,73,110.00Return on investment - most recent fiscal year
17.16Return on average assets - most recent fiscal year
13.85Receivables turnover - most recent fiscal year
4.56Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
2.03Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
1,50,24,090.00Return on average assets - 5 year average
14.78Net Income/employee - most recent fiscal year
18,87,063.00Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.97Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
18.07Return on investment - 5 year average
19.58